Covid vaccine: a new study in Argentina “confirmed the production of neutralizing antibodies in the blood of 100% of people vaccinated with Sputnik V”. The results were presented yesterday during the technical-scientific online meeting between the directorates and researchers of the Inmi Spallanzani Irccs in Rome with the Nicolaj Gamaleya National Epidemiological and Microbiological Research Center and the Russo Investment Fund.
During the meeting, aspects related to “the development and clinical implementation of the Sputnik V vaccine and new monoclonal antibodies were discussed – the Inmi note specifies – The Russian group presented data on new aspects of impact studies in the elderly population. and towards the emerging variants of Sars-CoV-2 “. The conference was opened by the directors of the two institutes, Alexander Gintsburg and Francesco Vaia.
During the meeting “hypotheses of scientific collaboration were put forward that provide for the sharing of data, biological materials and technologies between the two Institutes. In particular – continues the Inmi – the Russian Investment Fund communicated the transfer of technologies in a series of countries outside the Russian Federation (including India, China, South Korea and Brazil) and the willingness to follow a similar path also in Italy “.
The two Institutes shared “the need to establish stable relationships of scientific collaboration aimed at the development and clinical evaluation of new vaccination and therapeutic strategies. We will soon draw up a memorandum of understanding between the two institutes”.